Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis.
Vandenbroucke K, de Haard H, Beirnaert E, Dreier T, Lauwereys M, Huyck L, Van Huysse J, Demetter P, Steidler L, Remaut E, Cuvelier C, Rottiers P.
Vandenbroucke K, et al. Among authors: huyck l.
Mucosal Immunol. 2010 Jan;3(1):49-56. doi: 10.1038/mi.2009.116. Epub 2009 Sep 30.
Mucosal Immunol. 2010.
PMID: 19794409
Free article.